Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment

OBJECTIVES: We aimed to identify the factors that predict the likelihood of remission based on a health assessment questionnaire (HAQ) in rheumatoid arthritis (RA) patients who received non-tumor necrosis factor (TNF) biologics for six months before they commenced definitive treatment. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Miwa, Yusuke, Saito, Mayu, Furuya, Hidekazu, Yanai, Ryo, Ikari, Yuzo, Hayashi, Tomoki, Kasama, Tsuyoshi, Toyoshima, Yoichi, Inagaki, Katsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635297/
https://www.ncbi.nlm.nih.gov/pubmed/28794381
http://dx.doi.org/10.2169/internalmedicine.8723-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635297/
https://www.ncbi.nlm.nih.gov/pubmed/28794381
http://dx.doi.org/10.2169/internalmedicine.8723-16

Ejemplares similares